Structure

Physi-Chem Properties

Molecular Weight:  454.27
Volume:  474.911
LogP:  4.288
LogD:  3.725
LogS:  -4.671
# Rotatable Bonds:  3
TPSA:  76.13
# H-Bond Aceptor:  5
# H-Bond Donor:  1
# Rings:  6
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.389
Synthetic Accessibility Score:  5.799
Fsp3:  0.786
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.866
MDCK Permeability:  1.3717884030484129e-05
Pgp-inhibitor:  0.991
Pgp-substrate:  0.856
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.053
30% Bioavailability (F30%):  0.333

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.626
Plasma Protein Binding (PPB):  82.3581314086914%
Volume Distribution (VD):  1.055
Pgp-substrate:  7.09091854095459%

ADMET: Metabolism

CYP1A2-inhibitor:  0.046
CYP1A2-substrate:  0.428
CYP2C19-inhibitor:  0.307
CYP2C19-substrate:  0.82
CYP2C9-inhibitor:  0.318
CYP2C9-substrate:  0.05
CYP2D6-inhibitor:  0.033
CYP2D6-substrate:  0.128
CYP3A4-inhibitor:  0.921
CYP3A4-substrate:  0.774

ADMET: Excretion

Clearance (CL):  15.884
Half-life (T1/2):  0.513

ADMET: Toxicity

hERG Blockers:  0.693
Human Hepatotoxicity (H-HT):  0.368
Drug-inuced Liver Injury (DILI):  0.493
AMES Toxicity:  0.023
Rat Oral Acute Toxicity:  0.883
Maximum Recommended Daily Dose:  0.321
Skin Sensitization:  0.914
Carcinogencity:  0.818
Eye Corrosion:  0.12
Eye Irritation:  0.216
Respiratory Toxicity:  0.979

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC122056

Natural Product ID:  NPC122056
Common Name*:   Jaborosalactone A
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  PQCMITGKFWXOBO-GOXWLBPLSA-N
Standard InCHI:  InChI=1S/C28H38O5/c1-15-12-22(32-25(31)18(15)14-29)16(2)19-7-8-20-17-13-24-28(33-24)10-5-6-23(30)27(28,4)21(17)9-11-26(19,20)3/h5-6,16-17,19-22,24,29H,7-14H2,1-4H3/t16-,17-,19+,20-,21-,22+,24+,26+,27-,28+/m0/s1
SMILES:  CC1=C(CO)C(=O)O[C@H](C1)[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@@H]4[C@@]5(CC=CC(=O)[C@]5(C)[C@H]3CC[C@]12C)O4
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL465075
PubChem CID:   12304656
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001125] Steroid lactones
          • [CHEMONTID:0001560] Withanolides and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18304 Jaborosa integrifolia Species Solanaceae Eukaryota n.a. n.a. n.a. PMID[12027740]
NPO18304 Jaborosa integrifolia Species Solanaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT440 Individual Protein Quinone oxidoreductase Mus musculus CQ = 0.68 uM PMID[510435]
NPT440 Individual Protein Quinone oxidoreductase Mus musculus CD = 0.29 uM PMID[510435]
NPT2 Others Unspecified Ratio = 6.3 n.a. PMID[510435]
NPT27 Others Unspecified IC50 = 1830.0 nM PMID[510435]
NPT2 Others Unspecified Ratio = 2.7 n.a. PMID[510435]
NPT776 Organism Spodoptera littoralis Spodoptera littoralis Inhibition = 74.0 % PMID[510436]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC122056 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.972 High Similarity NPC286528
0.972 High Similarity NPC167606
0.972 High Similarity NPC140055
0.972 High Similarity NPC20302
0.963 High Similarity NPC50774
0.963 High Similarity NPC709
0.9541 High Similarity NPC264954
0.9537 High Similarity NPC470493
0.9537 High Similarity NPC183580
0.9537 High Similarity NPC243065
0.9537 High Similarity NPC312824
0.9537 High Similarity NPC470492
0.9533 High Similarity NPC67259
0.9533 High Similarity NPC147912
0.9455 High Similarity NPC474370
0.9434 High Similarity NPC474315
0.9369 High Similarity NPC67569
0.9286 High Similarity NPC153700
0.9286 High Similarity NPC470265
0.9286 High Similarity NPC88326
0.9286 High Similarity NPC23786
0.9238 High Similarity NPC91034
0.9204 High Similarity NPC469789
0.9189 High Similarity NPC473274
0.9123 High Similarity NPC8374
0.9123 High Similarity NPC470494
0.9123 High Similarity NPC3381
0.9123 High Similarity NPC8369
0.9099 High Similarity NPC186525
0.9091 High Similarity NPC270929
0.9043 High Similarity NPC293112
0.9035 High Similarity NPC11895
0.9027 High Similarity NPC470878
0.9027 High Similarity NPC473256
0.9018 High Similarity NPC476960
0.8991 High Similarity NPC69291
0.8957 High Similarity NPC81736
0.8957 High Similarity NPC172154
0.8947 High Similarity NPC170538
0.8929 High Similarity NPC329736
0.8919 High Similarity NPC64318
0.8899 High Similarity NPC470960
0.887 High Similarity NPC204812
0.885 High Similarity NPC61520
0.885 High Similarity NPC473270
0.8839 High Similarity NPC476965
0.8839 High Similarity NPC470959
0.8829 High Similarity NPC284915
0.8818 High Similarity NPC191620
0.8818 High Similarity NPC476163
0.8814 High Similarity NPC473593
0.8807 High Similarity NPC29133
0.8796 High Similarity NPC220155
0.8793 High Similarity NPC241456
0.8793 High Similarity NPC32868
0.8772 High Similarity NPC476962
0.8727 High Similarity NPC470961
0.8718 High Similarity NPC473635
0.8684 High Similarity NPC475520
0.8667 High Similarity NPC476299
0.8667 High Similarity NPC231240
0.8667 High Similarity NPC474012
0.8654 High Similarity NPC253826
0.8644 High Similarity NPC156797
0.8636 High Similarity NPC37116
0.8611 High Similarity NPC266570
0.8609 High Similarity NPC476961
0.8598 High Similarity NPC475526
0.8598 High Similarity NPC476237
0.8598 High Similarity NPC72151
0.8598 High Similarity NPC329345
0.8598 High Similarity NPC473283
0.8598 High Similarity NPC112009
0.8598 High Similarity NPC297617
0.8595 High Similarity NPC316915
0.8585 High Similarity NPC282524
0.8571 High Similarity NPC478056
0.8571 High Similarity NPC98868
0.8571 High Similarity NPC25909
0.8571 High Similarity NPC316598
0.8545 High Similarity NPC475941
0.8545 High Similarity NPC474901
0.8545 High Similarity NPC475065
0.8534 High Similarity NPC46570
0.8532 High Similarity NPC329048
0.8532 High Similarity NPC475294
0.8532 High Similarity NPC473284
0.8532 High Similarity NPC330011
0.8522 High Similarity NPC470495
0.8509 High Similarity NPC239273
0.8505 High Similarity NPC320447
0.8505 High Similarity NPC155332
0.8505 High Similarity NPC32577
0.8505 High Similarity NPC136289
0.8505 High Similarity NPC114540
0.8496 Intermediate Similarity NPC238667
0.8496 Intermediate Similarity NPC470953
0.8487 Intermediate Similarity NPC287423
0.8482 Intermediate Similarity NPC475524
0.8482 Intermediate Similarity NPC475970
0.8482 Intermediate Similarity NPC100267
0.8482 Intermediate Similarity NPC236217
0.8462 Intermediate Similarity NPC269642
0.8462 Intermediate Similarity NPC107493
0.8455 Intermediate Similarity NPC475418
0.8455 Intermediate Similarity NPC318363
0.8455 Intermediate Similarity NPC473482
0.8448 Intermediate Similarity NPC268530
0.8448 Intermediate Similarity NPC154491
0.844 Intermediate Similarity NPC189863
0.8435 Intermediate Similarity NPC311554
0.8435 Intermediate Similarity NPC473720
0.8435 Intermediate Similarity NPC257457
0.8426 Intermediate Similarity NPC180204
0.8426 Intermediate Similarity NPC475050
0.8426 Intermediate Similarity NPC476889
0.8426 Intermediate Similarity NPC95899
0.8426 Intermediate Similarity NPC478057
0.8421 Intermediate Similarity NPC148458
0.8417 Intermediate Similarity NPC473620
0.8411 Intermediate Similarity NPC224720
0.8411 Intermediate Similarity NPC81530
0.8411 Intermediate Similarity NPC115899
0.8411 Intermediate Similarity NPC476240
0.8411 Intermediate Similarity NPC476223
0.8396 Intermediate Similarity NPC57079
0.8396 Intermediate Similarity NPC108368
0.839 Intermediate Similarity NPC120724
0.8381 Intermediate Similarity NPC242848
0.8376 Intermediate Similarity NPC159456
0.8376 Intermediate Similarity NPC4021
0.8362 Intermediate Similarity NPC42673
0.8362 Intermediate Similarity NPC475041
0.8348 Intermediate Similarity NPC55296
0.8348 Intermediate Similarity NPC474518
0.8348 Intermediate Similarity NPC476959
0.8348 Intermediate Similarity NPC469684
0.8348 Intermediate Similarity NPC471854
0.8347 Intermediate Similarity NPC476966
0.8333 Intermediate Similarity NPC474181
0.8333 Intermediate Similarity NPC473253
0.8333 Intermediate Similarity NPC476890
0.8333 Intermediate Similarity NPC40918
0.8319 Intermediate Similarity NPC90952
0.8319 Intermediate Similarity NPC277769
0.8319 Intermediate Similarity NPC285956
0.8318 Intermediate Similarity NPC266955
0.8318 Intermediate Similarity NPC476303
0.8318 Intermediate Similarity NPC201406
0.8318 Intermediate Similarity NPC476274
0.8304 Intermediate Similarity NPC473627
0.8304 Intermediate Similarity NPC16270
0.8302 Intermediate Similarity NPC2049
0.8302 Intermediate Similarity NPC108078
0.8302 Intermediate Similarity NPC156546
0.8302 Intermediate Similarity NPC126815
0.8291 Intermediate Similarity NPC251226
0.8288 Intermediate Similarity NPC322903
0.8288 Intermediate Similarity NPC472825
0.8288 Intermediate Similarity NPC177064
0.8286 Intermediate Similarity NPC33473
0.8276 Intermediate Similarity NPC146786
0.8276 Intermediate Similarity NPC113448
0.8273 Intermediate Similarity NPC60681
0.8261 Intermediate Similarity NPC476963
0.8261 Intermediate Similarity NPC470075
0.8257 Intermediate Similarity NPC176883
0.8257 Intermediate Similarity NPC247957
0.8257 Intermediate Similarity NPC36688
0.8257 Intermediate Similarity NPC26478
0.8257 Intermediate Similarity NPC249187
0.8241 Intermediate Similarity NPC235142
0.8241 Intermediate Similarity NPC476897
0.8241 Intermediate Similarity NPC310981
0.8241 Intermediate Similarity NPC473514
0.8241 Intermediate Similarity NPC93744
0.8241 Intermediate Similarity NPC476888
0.8224 Intermediate Similarity NPC252295
0.822 Intermediate Similarity NPC470418
0.8214 Intermediate Similarity NPC137911
0.8214 Intermediate Similarity NPC5475
0.8214 Intermediate Similarity NPC472216
0.8214 Intermediate Similarity NPC173905
0.8214 Intermediate Similarity NPC284828
0.8214 Intermediate Similarity NPC228477
0.8208 Intermediate Similarity NPC471153
0.8208 Intermediate Similarity NPC195366
0.8208 Intermediate Similarity NPC301534
0.8208 Intermediate Similarity NPC250757
0.8208 Intermediate Similarity NPC29152
0.8208 Intermediate Similarity NPC114743
0.8205 Intermediate Similarity NPC472933
0.8205 Intermediate Similarity NPC230513
0.8198 Intermediate Similarity NPC263729
0.8198 Intermediate Similarity NPC472925
0.8198 Intermediate Similarity NPC79298
0.8198 Intermediate Similarity NPC43063
0.8198 Intermediate Similarity NPC301666
0.8198 Intermediate Similarity NPC470952
0.8197 Intermediate Similarity NPC231529

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC122056 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.972 High Similarity NPD7115 Discovery
0.8125 Intermediate Similarity NPD6881 Approved
0.8125 Intermediate Similarity NPD6899 Approved
0.807 Intermediate Similarity NPD6649 Approved
0.807 Intermediate Similarity NPD6650 Approved
0.8056 Intermediate Similarity NPD4225 Approved
0.8036 Intermediate Similarity NPD5697 Approved
0.7982 Intermediate Similarity NPD7639 Approved
0.7982 Intermediate Similarity NPD7290 Approved
0.7982 Intermediate Similarity NPD7640 Approved
0.7982 Intermediate Similarity NPD7102 Approved
0.7982 Intermediate Similarity NPD6883 Approved
0.7946 Intermediate Similarity NPD6675 Approved
0.7946 Intermediate Similarity NPD6402 Approved
0.7946 Intermediate Similarity NPD7128 Approved
0.7946 Intermediate Similarity NPD5739 Approved
0.7925 Intermediate Similarity NPD6399 Phase 3
0.7913 Intermediate Similarity NPD6869 Approved
0.7913 Intermediate Similarity NPD8130 Phase 1
0.7913 Intermediate Similarity NPD6847 Approved
0.7913 Intermediate Similarity NPD6617 Approved
0.7895 Intermediate Similarity NPD6373 Approved
0.7895 Intermediate Similarity NPD6013 Approved
0.7895 Intermediate Similarity NPD6012 Approved
0.7895 Intermediate Similarity NPD6372 Approved
0.7895 Intermediate Similarity NPD6014 Approved
0.789 Intermediate Similarity NPD7638 Approved
0.7845 Intermediate Similarity NPD6882 Approved
0.7845 Intermediate Similarity NPD8297 Approved
0.7838 Intermediate Similarity NPD5211 Phase 2
0.783 Intermediate Similarity NPD6079 Approved
0.7807 Intermediate Similarity NPD7320 Approved
0.7807 Intermediate Similarity NPD6011 Approved
0.7798 Intermediate Similarity NPD6083 Phase 2
0.7798 Intermediate Similarity NPD6084 Phase 2
0.7736 Intermediate Similarity NPD5785 Approved
0.7719 Intermediate Similarity NPD5701 Approved
0.7699 Intermediate Similarity NPD5141 Approved
0.7692 Intermediate Similarity NPD3618 Phase 1
0.7685 Intermediate Similarity NPD7748 Approved
0.7664 Intermediate Similarity NPD7515 Phase 2
0.7658 Intermediate Similarity NPD5285 Approved
0.7658 Intermediate Similarity NPD5286 Approved
0.7658 Intermediate Similarity NPD4696 Approved
0.7642 Intermediate Similarity NPD5328 Approved
0.7636 Intermediate Similarity NPD7902 Approved
0.7632 Intermediate Similarity NPD6008 Approved
0.7615 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7568 Intermediate Similarity NPD5696 Approved
0.7545 Intermediate Similarity NPD5222 Approved
0.7545 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD5221 Approved
0.7541 Intermediate Similarity NPD6319 Approved
0.7524 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7522 Intermediate Similarity NPD5224 Approved
0.7522 Intermediate Similarity NPD5225 Approved
0.7522 Intermediate Similarity NPD5226 Approved
0.7522 Intermediate Similarity NPD4633 Approved
0.75 Intermediate Similarity NPD4786 Approved
0.7477 Intermediate Similarity NPD4755 Approved
0.7477 Intermediate Similarity NPD5173 Approved
0.7459 Intermediate Similarity NPD7101 Approved
0.7459 Intermediate Similarity NPD7100 Approved
0.7458 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD5175 Approved
0.7456 Intermediate Similarity NPD5174 Approved
0.7455 Intermediate Similarity NPD4629 Approved
0.7455 Intermediate Similarity NPD5210 Approved
0.7455 Intermediate Similarity NPD5695 Phase 3
0.744 Intermediate Similarity NPD7492 Approved
0.7436 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7434 Intermediate Similarity NPD5223 Approved
0.7431 Intermediate Similarity NPD4202 Approved
0.7429 Intermediate Similarity NPD1694 Approved
0.7402 Intermediate Similarity NPD7736 Approved
0.7398 Intermediate Similarity NPD6054 Approved
0.7387 Intermediate Similarity NPD4697 Phase 3
0.7383 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7383 Intermediate Similarity NPD6672 Approved
0.7383 Intermediate Similarity NPD5737 Approved
0.7381 Intermediate Similarity NPD6616 Approved
0.7377 Intermediate Similarity NPD6335 Approved
0.7373 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7373 Intermediate Similarity NPD4634 Approved
0.7368 Intermediate Similarity NPD7632 Discontinued
0.7364 Intermediate Similarity NPD7900 Approved
0.7364 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD6684 Approved
0.7358 Intermediate Similarity NPD5330 Approved
0.7358 Intermediate Similarity NPD7521 Approved
0.7358 Intermediate Similarity NPD6409 Approved
0.7358 Intermediate Similarity NPD7146 Approved
0.7358 Intermediate Similarity NPD7334 Approved
0.7355 Intermediate Similarity NPD6868 Approved
0.7355 Intermediate Similarity NPD6274 Approved
0.7345 Intermediate Similarity NPD4700 Approved
0.7344 Intermediate Similarity NPD7319 Approved
0.7339 Intermediate Similarity NPD5693 Phase 1
0.7339 Intermediate Similarity NPD8035 Phase 2
0.7339 Intermediate Similarity NPD7637 Suspended
0.7339 Intermediate Similarity NPD8034 Phase 2
0.7333 Intermediate Similarity NPD4632 Approved
0.7323 Intermediate Similarity NPD7078 Approved
0.7315 Intermediate Similarity NPD4753 Phase 2
0.7308 Intermediate Similarity NPD3667 Approved
0.7295 Intermediate Similarity NPD6317 Approved
0.729 Intermediate Similarity NPD3573 Approved
0.728 Intermediate Similarity NPD6370 Approved
0.7264 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7264 Intermediate Similarity NPD5363 Approved
0.725 Intermediate Similarity NPD6053 Discontinued
0.7244 Intermediate Similarity NPD7507 Approved
0.7236 Intermediate Similarity NPD6314 Approved
0.7236 Intermediate Similarity NPD6313 Approved
0.7227 Intermediate Similarity NPD6371 Approved
0.7222 Intermediate Similarity NPD7604 Phase 2
0.7222 Intermediate Similarity NPD6903 Approved
0.7207 Intermediate Similarity NPD6001 Approved
0.7203 Intermediate Similarity NPD4730 Approved
0.7203 Intermediate Similarity NPD4729 Approved
0.72 Intermediate Similarity NPD7503 Approved
0.72 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD6016 Approved
0.72 Intermediate Similarity NPD6015 Approved
0.7182 Intermediate Similarity NPD5284 Approved
0.7182 Intermediate Similarity NPD6411 Approved
0.7182 Intermediate Similarity NPD5281 Approved
0.717 Intermediate Similarity NPD3133 Approved
0.717 Intermediate Similarity NPD3665 Phase 1
0.717 Intermediate Similarity NPD3666 Approved
0.7156 Intermediate Similarity NPD6673 Approved
0.7156 Intermediate Similarity NPD6080 Approved
0.7156 Intermediate Similarity NPD6904 Approved
0.7154 Intermediate Similarity NPD6009 Approved
0.7143 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5988 Approved
0.7143 Intermediate Similarity NPD1698 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD6059 Approved
0.7119 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD5779 Approved
0.7117 Intermediate Similarity NPD5778 Approved
0.7083 Intermediate Similarity NPD5250 Approved
0.7083 Intermediate Similarity NPD5249 Phase 3
0.7083 Intermediate Similarity NPD5247 Approved
0.7083 Intermediate Similarity NPD5251 Approved
0.7083 Intermediate Similarity NPD5248 Approved
0.7063 Intermediate Similarity NPD6909 Approved
0.7063 Intermediate Similarity NPD5983 Phase 2
0.7063 Intermediate Similarity NPD6908 Approved
0.7059 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD6686 Approved
0.7059 Intermediate Similarity NPD5128 Approved
0.7054 Intermediate Similarity NPD8293 Discontinued
0.7034 Intermediate Similarity NPD4767 Approved
0.7034 Intermediate Similarity NPD4768 Approved
0.7025 Intermediate Similarity NPD5217 Approved
0.7025 Intermediate Similarity NPD5215 Approved
0.7025 Intermediate Similarity NPD5216 Approved
0.7009 Intermediate Similarity NPD4754 Approved
0.7 Intermediate Similarity NPD6101 Approved
0.7 Intermediate Similarity NPD6051 Approved
0.7 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.6983 Remote Similarity NPD5344 Discontinued
0.6981 Remote Similarity NPD4223 Phase 3
0.6981 Remote Similarity NPD4221 Approved
0.6981 Remote Similarity NPD4270 Approved
0.6981 Remote Similarity NPD4269 Approved
0.6977 Remote Similarity NPD6336 Discontinued
0.6975 Remote Similarity NPD6412 Phase 2
0.696 Remote Similarity NPD7328 Approved
0.696 Remote Similarity NPD7327 Approved
0.6944 Remote Similarity NPD5329 Approved
0.6942 Remote Similarity NPD5169 Approved
0.6942 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6942 Remote Similarity NPD5135 Approved
0.6937 Remote Similarity NPD5207 Approved
0.6929 Remote Similarity NPD8513 Phase 3
0.6929 Remote Similarity NPD8033 Approved
0.6923 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6917 Remote Similarity NPD5168 Approved
0.6909 Remote Similarity NPD5208 Approved
0.6905 Remote Similarity NPD7516 Approved
0.6887 Remote Similarity NPD5369 Approved
0.6885 Remote Similarity NPD5127 Approved
0.6881 Remote Similarity NPD5690 Phase 2
0.6881 Remote Similarity NPD5279 Phase 3
0.6881 Remote Similarity NPD5786 Approved
0.6881 Remote Similarity NPD6098 Approved
0.6881 Remote Similarity NPD4623 Approved
0.6881 Remote Similarity NPD4519 Discontinued
0.6875 Remote Similarity NPD6050 Approved
0.6875 Remote Similarity NPD5694 Approved
0.6852 Remote Similarity NPD4197 Approved
0.6852 Remote Similarity NPD3668 Phase 3
0.685 Remote Similarity NPD8377 Approved
0.685 Remote Similarity NPD8294 Approved
0.6822 Remote Similarity NPD8328 Phase 3
0.6797 Remote Similarity NPD8517 Approved
0.6797 Remote Similarity NPD8379 Approved
0.6797 Remote Similarity NPD8515 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data